PTLA Shares Outstanding History
Below is a table of the PTLA shares outstanding history going back to 5/22/2013:

Date PTLA Shares Outstanding
5/22/201332.36M
6/30/201335.17M
10/31/201339.71M
2/28/201441.03M
3/31/201441.12M
6/30/201441.40M
10/3/201448.63M
2/27/201548.95M
3/31/201552.04M
7/30/201552.56M
10/30/201552.71M
2/22/201656.36M
4/29/201656.47M
8/2/201656.50M
10/31/201656.54M
2/21/201756.56M
5/3/201757.02M
8/4/201757.66M
10/26/201765.25M
2/21/201865.39M
5/7/201865.83M
8/7/201866.09M
11/5/201866.43M
2/15/201966.82M
5/6/201968.11M
8/1/201968.32M
9/26/2019175004
11/1/201977.82M
2/20/202078.08M
5/1/202078.48M

Also see: PTLA Market Cap History
PTLA YTD Return
PTLA Historical Shares Outstanding:
+13.60% CAGR
PTLA Historical Shares Outstanding: +13.60% CAGR

Mouse over chart for data details
5/22/2013 ...5/1/2020
Portola Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic diseases and inflammation for patients who have limited or no approved treatment options. Co.'s primary product is Andexxa, an antidote for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. Bevyxxa is an anticoagulant approved for hospital and extended duration prophylaxis of venous thromboembolism in adult patients. Cerdulatinib is Co.'s investigational oral, dual spleen tyrosine kinase and janus kinase inhibitor. We show 30 historical shares outstanding datapoints in our coverage of PTLA's shares outstanding history.

Understanding the changing numbers of PTLA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PTLA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PTLA by allowing them to research PTLA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree PTLA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Portola Pharmaceuticals (PTLA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

PTPI Shares Outstanding History
PTX Shares Outstanding History
PULM Shares Outstanding History
QDEL Shares Outstanding History
QGEN Shares Outstanding History
QHC Shares Outstanding History
QLGN Shares Outstanding History
QNCX Shares Outstanding History
QTRX Shares Outstanding History
RAIN Shares Outstanding History
More Healthcare companies »

 

PTLA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.